Europe Nonalcoholic Fatty Liver Disease Market Report 2016

Europe Nonalcoholic Fatty Liver Disease Market Report 2016

1 Nonalcoholic Fatty Liver Disease Overview

1.1 Product Overview and Scope of Nonalcoholic Fatty Liver Disease

1.2 Classification of Nonalcoholic Fatty Liver Disease

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Nonalcoholic Fatty Liver Disease

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Nonalcoholic Fatty Liver Disease Market by Countries

1.4.1 Germany Status and Prospect (2011-2021)

1.4.2 France Status and Prospect (2011-2021)

1.4.3 UK Status and Prospect (2011-2021)

1.4.4 Russia Status and Prospect (2011-2021)

1.4.5 Italy Status and Prospect (2011-2021)

1.4.6 Spain Status and Prospect (2011-2021)

1.4.7 Benelux Status and Prospect (2011-2021)

1.5 Europe Market Size (Value and Volume) of Nonalcoholic Fatty Liver Disease (2011-2021)

1.5.1 Europe Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2021)

1.5.2 Europe Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)

2 Europe Nonalcoholic Fatty Liver Disease by Manufacturers, Type and Application

2.1 Europe Nonalcoholic Fatty Liver Disease Market Competition by Manufacturers

2.1.1 Europe Nonalcoholic Fatty Liver Disease Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Nonalcoholic Fatty Liver Disease Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Nonalcoholic Fatty Liver Disease (Volume and Value) by Type

2.2.1 Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Type (2011-2016)

2.2.2 Europe Nonalcoholic Fatty Liver Disease Revenue and Market Share by Type (2011-2016)

2.3 Europe Nonalcoholic Fatty Liver Disease (Volume and Value) by Countries

2.3.1 Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Countries (2011-2016)

2.3.2 Europe Nonalcoholic Fatty Liver Disease Revenue and Market Share by Countries (2011-2016)

2.4 Europe Nonalcoholic Fatty Liver Disease (Volume) by Application

3 Germany Nonalcoholic Fatty Liver Disease (Volume, Value and Sales Price)

3.1 Germany Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016)

3.1.1 Germany Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)

3.1.2 Germany Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)

3.1.3 Germany Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)

3.2 Germany Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers

3.3 Germany Nonalcoholic Fatty Liver Disease Sales and Market Share by Type

3.4 Germany Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

4 France Nonalcoholic Fatty Liver Disease (Volume, Value and Sales Price)

4.1 France Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016)

4.1.1 France Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)

4.1.2 France Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)

4.1.4 France Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)

4.2 France Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers

4.3 France Nonalcoholic Fatty Liver Disease Sales and Market Share by Type

4.4 France Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

5 UK Nonalcoholic Fatty Liver Disease (Volume, Value and Sales Price)

5.1 UK Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016)

5.1.1 UK Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)

5.1.2 UK Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)

5.1.5 UK Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)

5.2 UK Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers

5.3 UK Nonalcoholic Fatty Liver Disease Sales and Market Share by Type

5.4 UK Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

6 Russia Nonalcoholic Fatty Liver Disease (Volume, Value and Sales Price)

6.1 Russia Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016)

6.1.1 Russia Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)

6.1.2 Russia Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)

6.1.6 Russia Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)

6.2 Russia Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers

6.3 Russia Nonalcoholic Fatty Liver Disease Sales and Market Share by Type

6.4 Russia Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

7 Italy Nonalcoholic Fatty Liver Disease (Volume, Value and Sales Price)

7.1 Italy Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016)

7.1.1 Italy Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)

7.1.2 Italy Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)

7.1.7 Italy Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)

7.2 Italy Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers

7.3 Italy Nonalcoholic Fatty Liver Disease Sales and Market Share by Type

7.4 Italy Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

8 Spain Nonalcoholic Fatty Liver Disease (Volume, Value and Sales Price)

8.1 Spain Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016)

8.1.1 Spain Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)

8.1.2 Spain Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)

8.1.8 Spain Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)

8.2 Spain Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers

8.3 Spain Nonalcoholic Fatty Liver Disease Sales and Market Share by Type

8.4 Spain Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

9 Benelux Nonalcoholic Fatty Liver Disease (Volume, Value and Sales Price)

9.1 Benelux Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016)

9.1.1 Benelux Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)

9.1.2 Benelux Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)

9.1.9 Benelux Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)

9.2 Benelux Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers

9.3 Benelux Nonalcoholic Fatty Liver Disease Sales and Market Share by Type

9.4 Benelux Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

10 Europe Nonalcoholic Fatty Liver Disease Manufacturers Analysis

10.1 Conatus Pharmaceuticals

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification

10.1.2.1 Type I

10.1.2.2 Type II

10.1.3 Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)

10.1.4 Main Business/Business Overview

10.2 Daewoong Pharmaceutical

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification

10.2.2.1 Type I

10.2.2.2 Type II

10.2.3 Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)

10.2.4 Main Business/Business Overview

10.3 Galmed International

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification

10.3.2.1 Type I

10.3.2.2 Type II

10.3.3 Galmed International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)

10.3.4 Main Business/Business Overview

10.4 Kyorin Pharmaceutical

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification

10.4.2.1 Type I

10.4.2.2 Type II

10.4.3 Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)

10.4.4 Main Business/Business Overview

10.5 Metabolic Solutions Development

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification

10.5.2.1 Type I

10.5.2.2 Type II

10.5.3 Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)

10.5.4 Main Business/Business Overview

10.6 Novartis AG

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification

10.6.2.1 Type I

10.6.2.2 Type II

10.6.3 Novartis AG Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)

10.6.4 Main Business/Business Overview

10.7 Phenex Pharmaceuticals

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification

10.7.2.1 Type I

10.7.2.2 Type II

10.7.3 Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)

10.7.4 Main Business/Business Overview

10.8 Raptor Pharmaceuticals

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification

10.8.2.1 Type I

10.8.2.2 Type II

10.8.3 Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)

10.8.4 Main Business/Business Overview

10.9 TCM Biotech International

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification

10.9.2.1 Type I

10.9.2.2 Type II

10.9.3 TCM Biotech International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)

10.9.4 Main Business/Business Overview

10.10 Tobira Therapeutics

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification

10.10.2.1 Type I

10.10.2.2 Type II

10.10.3 Tobira Therapeutics Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)

10.10.4 Main Business/Business Overview

11 Nonalcoholic Fatty Liver Disease Manufacturing Cost Analysis

11.1 Nonalcoholic Fatty Liver Disease Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Nonalcoholic Fatty Liver Disease

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Nonalcoholic Fatty Liver Disease Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe Nonalcoholic Fatty Liver Disease Market Forecast (2016-2021)

14.1 Germany Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021)

14.2 France Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021)

14.3 UK Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021)

14.4 Russia Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021)

14.5 Italy Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021)

14.6 Spain Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021)

14.7 Benelux Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021)

14.8 Europe Nonalcoholic Fatty Liver Disease Sales Forecast by Type (2016-2021)

14.9 Europe Nonalcoholic Fatty Liver Disease Sales Forecast by Application (2016-2021)

15 Research Findings and Conclusion

16 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Nonalcoholic Fatty Liver Disease

Table Classification of Nonalcoholic Fatty Liver Disease

Figure Europe Sales Market Share of Nonalcoholic Fatty Liver Disease by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Application of Nonalcoholic Fatty Liver Disease

Figure Europe Sales Market Share of Nonalcoholic Fatty Liver Disease by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure Germany Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)

Figure France Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)

Figure UK Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)

Figure Russia Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)

Figure Italy Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)

Figure Spain Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)

Figure Benelux Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)

Figure Europe Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2021)

Figure Europe Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)

Table Europe Nonalcoholic Fatty Liver Disease Sales of Key Manufacturers (2015 and 2016)

Table Europe Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers

Figure 2016 Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers

Table Europe Nonalcoholic Fatty Liver Disease Revenue by Manufacturers (2015 and 2016)

Table Europe Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers

Table 2016 Europe Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers

Table Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Type (2011-2016)

Table Europe Nonalcoholic Fatty Liver Disease Sales Share by Type (2011-2016)

Figure Sales Market Share of Nonalcoholic Fatty Liver Disease by Type (2011-2016)

Figure Europe Nonalcoholic Fatty Liver Disease Sales Growth Rate by Type (2011-2016)

Table Europe Nonalcoholic Fatty Liver Disease Revenue and Market Share by Type (2011-2016)

Table Europe Nonalcoholic Fatty Liver Disease Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Nonalcoholic Fatty Liver Disease by Type (2011-2016)

Figure Europe Nonalcoholic Fatty Liver Disease Revenue Growth Rate by Type (2011-2016)

Table Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Countries (2011-2016)

Table Europe Nonalcoholic Fatty Liver Disease Sales Share by Countries (2011-2016)

Figure Sales Market Share of Nonalcoholic Fatty Liver Disease by Countries (2011-2016)

Table Europe Nonalcoholic Fatty Liver Disease Revenue and Market Share by Countries (2011-2016)

Table Europe Nonalcoholic Fatty Liver Disease Revenue Share by Countries (2011-2016)

Figure Revenue Market Share of Nonalcoholic Fatty Liver Disease by Countries (2011-2016)

Table Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Application (2011-2016)

Table Europe Nonalcoholic Fatty Liver Disease Sales Share by Application (2011-2016)

Figure Sales Market Share of Nonalcoholic Fatty Liver Disease by Application (2011-2016)

Figure Germany Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)

Figure Germany Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)

Figure Germany Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)

Table Germany Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)

Table Germany Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)

Table Germany Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)

Table Germany Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)

Table Germany Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)

Table Germany Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)

Figure France Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)

Figure France Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)

Figure France Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)

Table France Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)

Table France Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)

Table France Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)

Table France Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)

Table France Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)

Table France Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)

Figure UK Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)

Figure UK Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)

Figure UK Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)

Table UK Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)

Table UK Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)

Table UK Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)

Table UK Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)

Table UK Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)

Table UK Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)

Figure Russia Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)

Figure Russia Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)

Figure Russia Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)

Table Russia Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)

Table Russia Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)

Table Russia Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)

Table Russia Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)

Table Russia Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)

Table Russia Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)

Figure Italy Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)

Figure Italy Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)

Figure Italy Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)

Table Italy Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)

Table Italy Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)

Table Italy Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)

Table Italy Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)

Table Italy Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)

Table Italy Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)

Figure Spain Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)

Figure Spain Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)

Figure Spain Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)

Table Spain Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)

Table Spain Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)

Table Spain Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)

Table Spain Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)

Table Spain Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)

Table Spain Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)

Figure Benelux Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)

Figure Benelux Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)

Figure Benelux Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)

Table Benelux Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)

Table Benelux Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)

Table Benelux Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)

Table Benelux Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)

Table Benelux Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)

Table Benelux Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)

Table Nonalcoholic Fatty Liver Disease Basic Information List

Table Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)

Table Daewoong Pharmaceutical Basic Information List

Table Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)

Table Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)

Table Galmed International Basic Information List

Table Galmed International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)

Table Galmed International Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)

Table Kyorin Pharmaceutical Basic Information List

Table Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)

Table Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)

Table Metabolic Solutions Development Basic Information List

Table Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)

Table Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)

Table Novartis AG Basic Information List

Table Novartis AG Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novartis AG Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)

Table Phenex Pharmaceuticals Basic Information List

Table Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)

Table Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)

Table Raptor Pharmaceuticals Basic Information List

Table Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)

Table Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)

Table TCM Biotech International Basic Information List

Table TCM Biotech International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)

Table TCM Biotech International Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)

Table Tobira Therapeutics Basic Information List

Table Tobira Therapeutics Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)

Table Tobira Therapeutics Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Nonalcoholic Fatty Liver Disease

Figure Manufacturing Process Analysis of Nonalcoholic Fatty Liver Disease

Figure Nonalcoholic Fatty Liver Disease Industrial Chain Analysis

Table Raw Materials Sources of Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015

Table Major Buyers of Nonalcoholic Fatty Liver Disease

Table Distributors/Traders List

Figure Germany Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021)

Figure Germany Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)

Figure France Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021)

Figure France Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)

Figure UK Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021)

Figure UK Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)

Figure Russia Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021)

Figure Russia Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)

Figure Italy Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021)

Figure Italy Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)

Figure Spain Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021)

Figure Spain Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)

Figure Benelux Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021)

Figure Benelux Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)

Table Europe Nonalcoholic Fatty Liver Disease Sales Forecast by Type (2016-2021)

Table Europe Nonalcoholic Fatty Liver Disease Sales Forecast by Application (2016-2021)